RT Journal Article
SR Electronic
T1 ADHD in adults with recurrent depression
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.02.05.21251211
DO 10.1101/2021.02.05.21251211
A1 Powell, Victoria
A1 Agha, Sharifah Shameem
A1 Jones, Rhys Bevan
A1 Eyre, Olga
A1 Thapar, Anita
A1 Rice, Frances
YR 2021
UL http://medrxiv.org/content/early/2021/02/08/2021.02.05.21251211.abstract
AB Background Depression is highly heterogeneous in its clinical presentation. Those with attention deficit/hyperactivity disorder (ADHD) may be at risk of a more chronic and impairing depression compared to those with depression alone according to studies of young people. However, no studies to date have examined ADHD in recurrently depressed adults in mid-life.Aims To investigate ADHD in women in mid-life with a history of recurrent depression.Method In a sample of women in mid-life (n=148) taken from a UK based prospective cohort of adults with a history of recurrent depression, we investigated the prevalence of ADHD and the association of ADHD with clinical features of depression.Results 12.8% of the recurrently depressed women had elevated ADHD symptoms and 3.4% met DSM-5 diagnostic criteria for ADHD. None of the women reported having a diagnosis of ADHD from a medical professional. ADHD was associated with earlier age of depression onset, higher depression associated impairment, a greater recurrence of depressive episodes and increased persistence of subthreshold depression symptoms over the study period, higher levels of irritability and increased risk of self-harm or suicide attempt. ADHD symptoms were associated with increased risk of hospitalisation and receiving non-first line antidepressant medication.Conclusions Higher ADHD symptoms appear to index a worse clinical presentation for depression. Findings suggest that in women with early onset, impairing and recurrent depression, the possibility of underlying ADHD masked by depression needs to be considered.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe work was supported by the Medical Research Council (MR/R004609/1). The cohort was established with funding from the Jules Thorn Charitable Trust (JTA/06).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethical approval was granted by the Multi-Centre Research Ethics Committee for Wales and from the School of Medicine Ethics Committee, Cardiff University.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data that support the findings of this study are available on reasonable request from the corresponding author, Victoria Powell. The data are not publicly available due to their containing information that could compromise the privacy of research participants.